Evidence map›Paper›PMID 12922957›Full record

ArticleAnnals of the rheumatic diseases2003

Factors associated with coronary artery calcification in young female patients with SLE.

K Manger, M Kusus, C Forster, D Ropers, W G Daniel, J R Kalden, S Achenbach, B Manger

Open access · bronzeAbstract read
In one paragraph

Article in Annals of the rheumatic diseases, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 151 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. New insight of complement system in the process of vascular calcification.Journal of cellular and molecular medicine · 2023
    Review
  6. Cardiovascular disease in systemic lupus erythematosus.Rheumatology and immunology research · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Pathogenesis and treatment of atherosclerosis in lupus.Rheumatic diseases clinics of North America · 2014
    Review
  16. Complement protein C3 and coronary artery calcium in middle-aged women with polycystic ovary syndrome and controls.Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2014
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

K MangerDepartment of Internal Medicine III and Institute for Clinical Immunology, University Erlangen-Nuremberg, Germany. Department of Internal Medicine II, University Erlangen-Nuremberg, Germany. karin.manger@med.imed.uni-erlangen.de
M Kusus
C Forster
D Ropers
W G Daniel
J R Kalden
S Achenbach
B Manger
Friedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith improved survival rates of patients with systemic lupus erythematosus (SLE), damage such as accelerated atherosclerosis gains increasing importance.

objectiveTo identify the prevalence of coronary artery calcifications (CAC) in asymptomatic patients.

methodsElectron beam tomography (EBT) was performed in 75 female patients with SLE aged <50. The results were correlated with traditional and SLE related factors associated with CAC. 49 women with symptomatic coronary heart disease (CHD) and 279 women without CHD were also analysed.

resultsOverall, 21/75 (28%) patients had CAC. Low HDL cholesterol levels <1.40 mmol/l (p=0.03, OR=1.8, 67% v 39%) and cigarette smoking (p=0.01, OR=5.7, 76% v 44%) were identified as factors associated with CAC. Hypertension and high cholesterol were more common in women with CHD (p<0.01) than in those without CHD. SLE related factors were proteinuria (1331 v 465 mg/day, p=0.02), impaired renal function (p=0.02, OR=2.6, 26% v 6%), and high C3 levels (p=0.04, OR=1.8, 65% v 38%). High C3 levels were also more common in symptomatic CHD (p=0.02). The prevalence of Sm antibodies was lower in patients with CAC (15% v 42%, p=0.03). In a multivariate analysis, cigarette smoking, reduced renal function, high C3, and a cumulative steroid dose above 30 g were the most important CAC associated factors in the lupus cohort.

conclusionA subgroup of patients with SLE with CAC without any clinical symptoms of CHD was identified by EBT. Therefore, EBT is useful for assessing asymptomatic atherosclerosis in this group.

Indexed as

AdultAge FactorsCalcinosisCoronary Artery DiseaseFemaleHumansKidneyLupus Erythematosus, SystemicMiddle AgedMultivariate AnalysisProteinuriaRisk FactorsSmokingTomography, X-Ray Computed

Identifiers

PMID12922957
PMCPMC1754656
OpenAlexW2110314624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.